This review will discuss issues arising along with the expanding use of hypomethylating treatment (HMT) in the management of acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS)
Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases characterized by ineffective h...
The review describes epigenetic processes, including methylation of nuclear and mitochondrial DNA, a...
Epigenetic mechanisms affecting chromatin structure contribute to regulate gene expression and assur...
This review will discuss issues arising along with the expanding use of hypomethylating treatment (H...
Steven E McCormack, Erica D WarlickDepartment of Medicine, Division of Hematology, Oncology, and Tra...
The current therapy of high-risk MDS and AML is reliant on cytotoxic chemotherapy and is often deliv...
Myeloid hematological malignancies are clonal bone marrow neoplasms, comprising of acute myeloid leu...
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA hypomethylat...
The term epigenetics refers to a number of biochemi-cal modifications of chromatin that, without alt...
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic diseases, mainly affecting ...
Epigenetic therapies of cancer have been intensely studied, because of the high frequency of epigene...
The myelodysplastic syndrome (MDS) is a clonal disorder characterized by in-creased stem cell prolif...
Epigenetic changes play an important role in the development of acute myeloid leukemia (AML). Unlike...
Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. AML is a heterogen...
The purpose of this review is to update knowledge on therapy-related myeloid neoplasms (t-MNs), take...
Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases characterized by ineffective h...
The review describes epigenetic processes, including methylation of nuclear and mitochondrial DNA, a...
Epigenetic mechanisms affecting chromatin structure contribute to regulate gene expression and assur...
This review will discuss issues arising along with the expanding use of hypomethylating treatment (H...
Steven E McCormack, Erica D WarlickDepartment of Medicine, Division of Hematology, Oncology, and Tra...
The current therapy of high-risk MDS and AML is reliant on cytotoxic chemotherapy and is often deliv...
Myeloid hematological malignancies are clonal bone marrow neoplasms, comprising of acute myeloid leu...
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA hypomethylat...
The term epigenetics refers to a number of biochemi-cal modifications of chromatin that, without alt...
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic diseases, mainly affecting ...
Epigenetic therapies of cancer have been intensely studied, because of the high frequency of epigene...
The myelodysplastic syndrome (MDS) is a clonal disorder characterized by in-creased stem cell prolif...
Epigenetic changes play an important role in the development of acute myeloid leukemia (AML). Unlike...
Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. AML is a heterogen...
The purpose of this review is to update knowledge on therapy-related myeloid neoplasms (t-MNs), take...
Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases characterized by ineffective h...
The review describes epigenetic processes, including methylation of nuclear and mitochondrial DNA, a...
Epigenetic mechanisms affecting chromatin structure contribute to regulate gene expression and assur...
DOI